BridgeMD
New treatment option for Advanced Sarcoma
Official title Study of the Impact of Digital Health Interventions on Symptom & Side-Effect Management in Metastatic Sarcoma Patients
ClinicalTrials.gov ID: NCT07642375
What this study is testing
- What it's testing
- The objective of this prospective study is to capture the quality of life of patients with locally advanced or metastatic sarcoma, and investigate the effectiveness of support provided through a personalized web-based platform.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age of ≥ 18 years.
- Diagnosis of locally advanced or metastatic sarcoma of any location and origin.
- Ability to understand and operate in a digital environment.
- Patients planned to start standard of care treatment within the next month, or are currently undergoing standard of care treatment of any line.
- Treatments include surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy, hormonal therapy, or any combination of the above.
You likely can't join if
- Limited ability or willingness to report side-effects on an online platform.
- Performance status \>3.
- Life expectancy of \<6 months.
- Participation in an treatment clinical trial with investigational drugs or devices.
The study team makes the final eligibility decision.
Where it's taking place
- Athens, Greece
- Thessaloniki, Greece
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Athens, Greece; Thessaloniki, Greece. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.